Last updated: January 17, 2025
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Overall Status: Active - Recruiting
Phase
N/A
Condition
Tic Disorders
Neurologic Disorders
Autism
Treatment
N/AClinical Study ID
NCT06782802
CSP21
Ages 28-44 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pregnant participants with a diagnosis of cavum septum pellucidum obliteration madeat second-trimester morphologic ultrasound between 19+0 and 21+6 weeks
Age > or = 18 years at the time of outpatient access
Acquisition of informed consent form, from the patient and minor
Patients followed at our center
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 15
Study Start date:
March 07, 2022
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.